A detailed history of Gold Investment Management Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Gold Investment Management Ltd. holds 7,972 shares of ABBV stock, worth $1.43 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
7,972
Previous 11,062 27.93%
Holding current value
$1.43 Million
Previous $1.9 Billion 17.7%
% of portfolio
0.65%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $506,265 - $615,929
-3,090 Reduced 27.93%
7,972 $1.56 Billion
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $171,971 - $200,824
-1,111 Reduced 9.13%
11,062 $1.9 Billion
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $124,659 - $142,038
-780 Reduced 6.02%
12,173 $2.22 Billion
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $1.78 Million - $2.01 Million
12,953 New
12,953 $2.01 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gold Investment Management Ltd. Portfolio

Follow Gold Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gold Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gold Investment Management Ltd. with notifications on news.